Summary
Tumour cell invasion and metastasis is a multistep process that involves the degradation of extracellular matrix proteins by matrix metalloproteinases (MMPs). Tissue inhibitors of metalloproteinases (TIMPs) act as negative regulators of MMPs and thus prevent tumour cell invasion and metastasis by preserving extracellular matrix (ECM) integrity. In the present study we examined the expression of one member of TIMPs, TIMP-1, in 39 thyroid tumour specimens and two thyroid carcinoma cell lines (NPA and SW579). We also investigated the effect of high TIMP-1 expression on the invasive potential of NPA cells. Northern blot analysis showed that TIMP-1 mRNA levels correlated directly with tumour aggressiveness: the highest number of TIMP-1 transcripts was found in stages III and IV vs benign goitre (P < 0.0001). However, TIMP-1 expression was not increased in NPA and SW579 cells, both of which are derived from poorly differentiated thyroid tumours. Immunohistochemical study showed strong TIMP-1 staining in the stroma cells of advanced stages of carcinomas. Overexpression of TIMP-1 by gene transfer resulted in a significant suppression of the malignant phenotype of NPA cells as judged by an in vitro tumour invasion assay. These results suggest that high levels of TIMP-1 transcripts in advanced stages of thyroid carcinoma likely come from stroma rather than thyroid cancer cells, and TIMP-1 may function as a thyroid tumour invasion/metastasis suppressor.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M. & McEwan, R. N. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245.
Albini, A., Melchiori, A., Santi, L., Liotta, L. A., Brown, P. D. & Stetler-Stevenson, W. G. (1991). Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 83: 775–779.
Bernhard, E., Gruber, S. & Muschel, R. (1994). Direct evidence linking MMP-9 (92 kDa gelatinase/collagenase) expression to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 91: 4293–4297.
Carmichael, D. F., Sommer, A., Thompson, R. C., Anderson, D. C., Smith, C. G., Welgus, H. G. & Stricklin, G. P. (1986). Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 83: 2407–2411.
Chen, C. & Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745–2752.
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 162: 156–159.
DeClerck, Y. A., Yean, T-D, Ratzkin, B. J., Lu, H. S. & Langley, K. E. (1989). Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264: 17445–17453.
DeClerck, Y. A., Yean, T. D., Chan, D., Shimada, H. & Langley, K. E. (1991). Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 51: 2151–2157.
DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E. & Taylor, S. M. (1992). Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708.
Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S. M. & He, C. (1989). Human 72-kilodalton type IV collagenase forms a complex with tissue inhibitor of metalloproteinase designated TIMP-2. Proc Natl Acad Sci USA 86: 8207–8211.
Grignon, D., Sakr, W., Toth, M., Ravery, V., Angulo, J., Shamsa, F., Pontes, J. E., Crissman, J. C. & Fridman, R. (1996). High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 56: 1654–1659.
Hendrix, M. J., Seftor, E. A., Seftor, R. E. & Fidler, I. J. (1987). A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 38: 137–147.
Hermanek, P. & Sobin, L. H. (eds) (1987). TNM Classification of Malignant Tumors, pp. 33–35, Springer-Verlag: Berlin
Khokha, R., Zimmer, M. J., Wilson, S. M. & Chambers, A. F. (1992). Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 10: 365–370.
Khokha, R. (1994). Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86: 299–304.
Kohn, E. C. & Liotta, L. A. (1995). Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856–1862.
Kossakowska, A. E., Urbanski, S. J. & Edwards, D. R. (1991). Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin’s lymphomas. Blood 77: 2475–2481.
Leco, K. J., Apte, S. S., Taniguchi, G. T., Hawkes, S. P., Khokha, R., Schultz, G. A. & Edwards, D. R. (1997). Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett 401: 213–217.
Liotta, L. A. & Stetler-Stevenson, W. G. (1991). Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51 (suppl.): 5054s–5059s.
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M. & Shafie, S. (1980). Metastastic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond) 284: 67–68.
Liotta, L. A., Rao, C. N. & Wewer, U. M. (1986). Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 55: 1037–1057.
Liotta, L. A., Steeg, P. A. & Stetler-Stevenson, W. G. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336.
Lu, X., Levy, M., Weinstein, B. I. & Santella, R. M. (1991). Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. Cancer Res 51: 6231–6235.
Matrisian, L. M. (1992). Metalloproteinases and their inhibitors in tissue remodeling. Trends Genet 6: 121–125.
Montgomery, A. M., Mueller, B. M., Reisfeld, R. A., Taylor, S. M. & Declerck, Y. A. (1994). Effect of tissue inhibitor of metalloproteinase-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54: 5467–5473.
Murphy, G., Reynolds, J. & Hembry, R. M. (1989). Metalloproteinases and cancer invasion and metastasis. Int J Cancer 44: 757–760.
Nakano, A., Tani, E., Miyazaki, K., Yamamoto, Y. & Furuyama, J. (1995). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298–307.
Nakajima, M., Welch, D. R., Belloni, P. N. & Nicolson, G. L. (1987). Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 4869–4876.
Parhar, R. S., Shi, Y., Zou, M. J., Farid, N. R., Ernst, P. & Al-Sedairy, S. T. (1995). Effects of cytokine-mediated modulation of NM23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. Int J Cancer 60: 204–210.
Pavloff, N., Staskus, P. W., Kishnani, N. S. & Hawkes, S. P. (1992). A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 267: 17321–17326.
Ponto, A., Coulombe, B. & Skup, D. (1991). Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cell leading to increased levels of collagenolytic activity. Cancer Res 51: 2138–2143.
Shi, Y., Zou, M., Schmidt, H., Juhasz, F., Stensky, V., Robb, D. & Farid, N. R. (1991). High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Res 51: 2690–2693.
Soloway, P. D., Alexander, C. M., Werb, Z. & Jaenisch, R. (1996). Targeted mutagenesis of TIMP-1 reveals that lung tumor invasion is influenced by TIMP-1 genotype of the tumor but not by that of the host. Oncogene 13: 2307–2314.
Sreenath, T., Matrisan, L., Stetler-Stevenson, W., Gattoni-Celli, S. & Pozzatti, R. (1992). Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 52: 4942–4947.
Stetler-Stevenson, W. G., Krutzsch, H. C. & Liotta, L. A. (1989). Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374–17378.
Stetler-Stevenson, W. G., Aznavoorian, S. & Liotta, L. A. (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 4: 541–573.
Visscher, D. W., Hoyhtya, M., Ottosen, S. K., Liang, C-M, Sarkar, F. H., Crissman, J. D. & Fridman, R. (1994a). Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59: 339–344.
Visscher, D. W., Hoyhtya, M., Ottosen, S. K., Liang, C. M., Sarkar, F. H., Crissman, J. C. & Fridman, R. (1994b). Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59: 339–344.
Woessner, J. F. (1990). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145–2154.
Zeng, Z-S, Cohen, A. M., Zhang, Z-F, Stetler-Stevenson, W. & Guillem, J. G. (1995). Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res 1: 899–906.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Shi, Y., Parhar, R., Zou, M. et al. Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma. Br J Cancer 79, 1234–1239 (1999). https://doi.org/10.1038/sj.bjc.6690198
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690198
Keywords
This article is cited by
-
Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses
Journal of Otolaryngology - Head & Neck Surgery (2015)
-
Serum biomarkers of papillary thyroid cancer
Journal of Otolaryngology - Head & Neck Surgery (2013)
-
In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF V600E mutation status and together with hypoxia-related proteins predicts aggressive behavior
Virchows Archiv (2013)
-
Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome
Oncogene (2006)
-
S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma
British Journal of Cancer (2005)